Inozyme Pharma Inc Long-term Investment Intensity
Inozyme Pharma Inc long-term investment intensity. Inozyme Pharma Inc (INZY) has a Long-term Investment Intensity of 1.6% as of March 2021. Long-term investments of $2.55 Million represent 1.6% of total assets of $158.91 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Read INZY total debt and obligations for a breakdown of total debt and financial obligations.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Long-term Investment Intensity of Inozyme Pharma Inc (2020–2020)
Long-term investment intensity of Inozyme Pharma Inc from 2020 to 2020. This chart shows how Inozyme Pharma Inc's Long-term Investment Intensity has evolved across 1 annual periods from 2020 to 2020. As of March 2021, the intensity stands at 1.6%, reflecting long-term investments of $2.55 Million against total assets of $158.91 Million USD.
Inozyme Pharma Inc Long-term Investment Intensity by Year (2020–2020)
Inozyme Pharma Inc long-term investment intensity by year from 2020 to 2020. The table below presents the year-by-year Long-term Investment Intensity for Inozyme Pharma Inc from 2020 to 2020, covering 1 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see how large is Inozyme Pharma Inc's balance sheet.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2020 | 7.2% | $12.20 Million | $169.36 Million | — |